Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.88 CAD | +0.15% | -1.71% | +68.63% |
May. 10 | Transcript : Vitalhub Corp., Q1 2024 Earnings Call, May 10, 2024 | |
May. 10 | Vitalhub Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
- The company's profit outlook over the next few years is a strong asset.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- With an expected P/E ratio at 44.39 and 32.25 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company's enterprise value to sales, at 4.23 times its current sales, is high.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+68.63% | 256M | - | ||
-9.49% | 28.16B | C | ||
+25.35% | 8.33B | C- | ||
+33.25% | 4.39B | B- | ||
-35.85% | 2.43B | C- | ||
-9.44% | 1.6B | - | C+ | |
-13.39% | 1.5B | B | ||
-32.84% | 1.15B | - | ||
+7.80% | 964M | C | ||
-37.56% | 872M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- VHI Stock
- Ratings Vitalhub Corp.